LogicBio Therapeutics, Inc.

CIK 1664106 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for LogicBio Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2023SC 13G/A0000935836-23-000241
Feb 10, 2023SC 13D/A0001193125-23-032721
Nov 29, 202215-12G0001104659-22-122869
Nov 18, 2022EFFECT9999999995-22-003341
Nov 17, 202240000899243-22-036295
Nov 17, 202240000899243-22-036289
Nov 17, 202240000899243-22-036305
Nov 17, 202240000899243-22-036303
Nov 17, 202240000899243-22-036292
Nov 17, 202240000899243-22-036301
Nov 17, 202240000899243-22-036300
Nov 17, 202240000899243-22-036306
Nov 17, 202240000899243-22-036290
Nov 17, 202240000899243-22-036299
Nov 17, 202240000899243-22-036298
Nov 16, 20228-K0001104659-22-119520
Nov 16, 2022SC 14D9/A0001193125-22-286319
Nov 16, 202225-NSE0001354457-22-000651
Nov 16, 2022S-8 POS0001104659-22-119525
Nov 16, 2022S-8 POS0001104659-22-119526
Nov 16, 2022S-8 POS0001104659-22-119527
Nov 16, 2022SC TO-T/A0001104659-22-119357
Nov 16, 2022S-8 POS0001104659-22-119528
Nov 16, 2022POS AM0001104659-22-119524
Nov 14, 202210-Q0001564590-22-037503